目的探讨重型再生障碍性贫血(SAA)患者CD3+T细胞端粒长度及端粒结合蛋白(sheherin)基因表达情况。方法收集2011年5月至2012年5月天津医科大学总医院血液科诊断明确的20例SAA患者(初治患者9例,治疗后恢复患者1l例)及10名健康对照的骨髓标本,以免疫磁珠法分选CD3+T细胞,以Southern印迹法检测端粒长度;荧光定量PCR法检测sheherin核心蛋白:TRF1、TRF2、TPP1、POT1、RAP1、TIN2基因表达情况,并进行临床相关分析。结果SAA患者CD3+T细胞端粒长度初治组为(4.4±1.1)kb、恢复组为(5.8±1.0)kb,均明显短于对照组l(9.2±3.3)kb,P〈0.05]。且CD3+T细胞端粒长度与T细胞亚群(T辅助/T抑制)呈显著正相关(r=0.564,P=0.029)。初治组POTl表达水平显著低于恢复组[0.16(0.02~0.29)比1.17(0.82~1.86),P〈0.05]。初治组RAPl表达水平显著高于恢复组和对照组[4.14(1.93~6.92)比0.87(0.30~1.73)和0.62(0.45~4.07),均P〈0.05]。结论SAA患者T细胞存在端粒长度及相关蛋白基因表达异常,且与病情相关。
Objective To explore the changes in telomere length and gene expression of complex shelterin (composed of 6 core components: TRF1, TRF2, POT1, TIN2, TPP1 and RAPl ) in severe aplastie anemia (SAA). Methods Bone marrow samples were obtained from 20 SAA patients and l0 normal controls. CD3 +T cells were sorted by immunomagnetic separation. Telomere length was tested by Southern blot and the gene expressions of TRF1, TRF2, POTI, TIN2, TPP1 and RAP1 were detected by reverse transcription-PCR(RT-PCR). Results Telomeres of CD3+ T cells were found significantly shorter in SAA untreated ( (4.4 ±1.1 ) kb, n = 9 ) and recovering groups ( ( 5.8 ±1.0) kb, n = 11 ) than control group ( (9. 2 ± 3.3 ) kb, P 〈 0. 05 ). Telomere length of CD3 + T cells shortened with TH/S decreasing ( r = 0. 564, P = 0. 029). The mRNA expression of POT1 decreased in untreated SAA patients (0. 16 (0. 02 - 0. 29) )and over-expressed in recovering patients( 1.17(0. 82 - 1.86) ,P 〈0. 05). The mRNA expression of RAP1 was significantly higher in untreated patients (4. 14 (1.93 -6. 92))than that in recovering group (0. 87 (0. 30 - 1.73 ) ) and controls (0. 62 ( 0. 45 - 4.07 ), both P 〈 0. 05 ). Conclusion Changes in telomere length and shelterin gene expression occur in CD3 + T cells of SAA patients and may be correlated with disease severity.